Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature Review
  • Published:

EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders

Molecular Psychiatry volume 12, pages 1065–1078 (2007)Cite this article

Abstract

The excitatory amino acid transporter 2 (EAAT2) is responsible for the majority of glutamate uptake in the brain and its dysregulation has been associated with multiple psychiatric and neurological disorders. However, investigation of this molecule has been complicated by its complex pattern of alternative splicing, including three coding isoforms and multiple 5′- and 3′-UTRs that may have a regulatory function. It is likely that these sequences permit modulation of EAAT2 expression with spatial, temporal and or activity-dependent specificity; however, few studies have attempted to delineate the function of these sequences. Additionally, there are problems with the use of antibodies to study protein localization, possibly due to posttranslational modification of critical amino acid residues. This review describes what is currently known about the regulation of EAAT2 mRNA and protein isoforms and concludes with a summary of studies showing dysregulation of EAAT2 in psychiatric and neurological disorders. EAAT2 has been either primarily or secondarily implicated in a multitude of neuropsychiatric diseases in addition to the normal physiology of learning and memory. Thus, this molecule represents an intriguing therapeutic target once we improve our understanding of how it is regulated under normal conditions.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Hayashi T . Effects of sodium glutamate on the nervous system. Keio J Med 1954; 3: 192–193.

    Article  Google Scholar 

  2. Logan WJ, Snyder SH . Unique high affinity uptake systems for glycine, glutamic and aspartic acids in central nervous tissue of the rat. Nature 1971; 234: 297–299.

    Article  CAS  PubMed  Google Scholar 

  3. Haugeto O, Ullensvang K, Levy LM, Chaudhry FA, Honore T, Nielsen M et al. Brain glutamate transporter proteins form homomultimers. J Biol Chem 1996; 271: 27715–27722.

    Article  CAS  PubMed  Google Scholar 

  4. Pines G, Danbolt NC, Bjoras M, Zhang Y, Bendahan A, Eide L et al. Cloning and expression of a rat brain L-glutamate transporter. Nature 1992; 360: 464–467.

    Article  CAS  PubMed  Google Scholar 

  5. Kim SY, Chao W, Choi SY, Volsky DJ . Cloning and characterization of the 3′-untranslated region of the human excitatory amino acid transporter 2 transcript. J Neurochem 2003; 86: 1458–1467.

    Article  CAS  PubMed  Google Scholar 

  6. Shashidharan P, Wittenberg I, Plaitakis A . Molecular cloning of human brain glutamate/aspartate transporter II. Biochim Biophys Acta 1994; 1191: 393–396.

    Article  CAS  PubMed  Google Scholar 

  7. Sutherland ML, Delaney TA, Noebels JL . Molecular characterization of a high-affinity mouse glutamate transporter. Gene 1995; 162: 271–274.

    Article  CAS  PubMed  Google Scholar 

  8. Mukainaka Y, Tanaka K, Hagiwara T, Wada K . Molecular cloning of two glutamate transporter subtypes from mouse brain. Biochim Biophys Acta 1995; 1244: 233–237.

    Article  PubMed  Google Scholar 

  9. Zerangue N, Kavanaugh MP . Flux coupling in a neuronal glutamate transporter. Nature 1996; 383: 634–637.

    Article  CAS  PubMed  Google Scholar 

  10. Storck T, Schulte S, Hofmann K, Stoffel W . Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci USA 1992; 89: 10955–10959.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Schmitt A, Asan E, Puschel B, Kugler P . Cellular and regional distribution of the glutamate transporter GLAST in the CNS of rats: nonradioactive in situ hybridization and comparative immunocytochemistry. J Neurosci 1997; 17: 1–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kanai Y, Hediger MA . Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 1992; 360: 467–471.

    Article  CAS  PubMed  Google Scholar 

  13. Shashidharan P, Huntley GW, Meyer T, Morrison JH, Plaitakis A . Neuron-specific human glutamate transporter: molecular cloning, characterization and expression in human brain. Brain Res 1994; 662: 245–250.

    Article  CAS  PubMed  Google Scholar 

  14. Rothstein JD, Martin L, Levey AI, Dykes-Hoberg M, Jin L, Wu D et al. Localization of neuronal and glial glutamate transporters. Neuron 1994; 13: 713–725.

    Article  CAS  PubMed  Google Scholar 

  15. Fairman WA, Vandenberg RJ, Arriza JL, Kavanaugh MP, Amara SG . An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 1995; 375: 599–603.

    Article  CAS  PubMed  Google Scholar 

  16. Arriza JL, Eliasof S, Kavanaugh MP, Amara SG . Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc Natl Acad Sci USA 1997; 94: 4155–4160.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Danbolt NC . Glutamate uptake. Prog Neurobiol 2001; 65: 1–105.

    Article  CAS  PubMed  Google Scholar 

  18. Kanai Y, Hediger MA . The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects. Pflugers Arch 2004; 447: 469–479.

    Article  CAS  PubMed  Google Scholar 

  19. Arriza JL, Fairman WA, Wadiche JI, Murdoch GH, Kavanaugh MP, Amara SG . Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci 1994; 14: 5559–5569.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Dunlop J . Glutamate-based therapeutic approaches: targeting the glutamate transport system. Curr Opin Pharmacol 2006; 6: 103–107.

    Article  CAS  PubMed  Google Scholar 

  21. Marcaggi P, Attwell D . Role of glial amino acid transporters in synaptic transmission and brain energetics. Glia 2004; 47: 217–225.

    Article  PubMed  Google Scholar 

  22. Diamond JS, Jahr CE . Transporters buffer synaptically released glutamate on a submillisecond time scale. J Neurosci 1997; 17: 4672–4687.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Utsunomiya-Tate N, Endou H, Kanai Y . Tissue specific variants of glutamate transporter GLT-1. FEBS Lett 1997; 416: 312–316.

    Article  CAS  PubMed  Google Scholar 

  24. Chen W, Aoki C, Mahadomrongkul V, Gruber CE, Wang GJ, Blitzblau R et al. Expression of a variant form of the glutamate transporter GLT1 in neuronal cultures and in neurons and astrocytes in the rat brain. J Neurosci 2002; 22: 2142–2152.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Schmitt A, Asan E, Lesch KP, Kugler P . A splice variant of glutamate transporter GLT1/EAAT2 expressed in neurons: cloning and localization in rat nervous system. Neuroscience 2002; 109: 45–61.

    Article  CAS  PubMed  Google Scholar 

  26. Sullivan R, Rauen T, Fischer F, Wiessner M, Grewer C, Bicho A et al. Cloning, transport properties, and differential localization of two splice variants of GLT-1 in the rat CNS: implications for CNS glutamate homeostasis. Glia 2004; 45: 155–169.

    Article  PubMed  Google Scholar 

  27. Rauen T, Wiessner M, Sullivan R, Lee A, Pow DV . A new GLT1 splice variant: cloning and immunolocalization of GLT1c in the mammalian retina and brain. Neurochem Int 2004; 45: 1095–1106.

    Article  CAS  PubMed  Google Scholar 

  28. Picaud SA, Larsson HP, Grant GB, Lecar H, Werblin FS . Glutamate-gated chloride channel with glutamate-transporter-like properties in cone photoreceptors of the tiger salamander. J Neurophysiol 1995; 74: 1760–1771.

    Article  CAS  PubMed  Google Scholar 

  29. Munch C, Schwalenstocker B, Hermann C, Cirovic S, Stamm S, Ludolph A et al. Differential RNA cleavage and polyadenylation of the glutamate transporter EAAT2 in the human brain. Brain Res Mol Brain Res 2000; 80: 244–251.

    Article  CAS  PubMed  Google Scholar 

  30. Hesketh J . 3′-Untranslated regions are important in mRNA localization and translation: lessons from selenium and metallothionein. Biochem Soc Trans 2004; 32: 990–993.

    Article  CAS  PubMed  Google Scholar 

  31. Lai EC, Burks C, Posakony JW . The K box, a conserved 3′ UTR sequence motif, negatively regulates accumulation of enhancer of split complex transcripts. Development 1998; 125: 4077–4088.

    CAS  PubMed  Google Scholar 

  32. Lewis BP, Burge CB, Bartel DP . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15–20.

    Article  CAS  PubMed  Google Scholar 

  33. Lauriat TL, Richler E, McInnes LA . A quantitative regional expression profile of EAAT2 known and novel splice variants reopens the question of aberrant EAAT2 splicing in disease. Neurochem Int 2007; 50: 271–280.

    Article  CAS  PubMed  Google Scholar 

  34. Meyer T, Speer A, Meyer B, Sitte W, Kuther G, Ludolph AC . The glial glutamate transporter complementary DNA in patients with amyotrophic lateral sclerosis. Ann Neurol 1996; 40: 456–459.

    Article  CAS  PubMed  Google Scholar 

  35. Munch C, Schwalenstocker B, Knappenberger B, Liebau S, Volkel H, Ludolph AC et al. 5′-heterogeneity of the human excitatory amino acid transporter cDNA EAAT2 (GLT-1). Neuroreport 1998; 9: 1295–1297.

    Article  CAS  PubMed  Google Scholar 

  36. Munch C, Ebstein M, Seefried U, Zhu B, Stamm S, Landwehrmeyer GB et al. Alternative splicing of the 5′-sequences of the mouse EAAT2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis. J Neurochem 2002; 82: 594–603.

    Article  CAS  PubMed  Google Scholar 

  37. Rozyczka J, Engele J . Multiple 5′-splice variants of the rat glutamate transporter-1. Brain Res Mol Brain Res 2005; 133: 157–161.

    Article  CAS  PubMed  Google Scholar 

  38. Tian G, Lai L, Guo H, Lin Y, Butchbach ME, Chang Y et al. Translational control of glial glutamate transporter EAAT2 expression. J Biol Chem 2007; 282: 1727–1737.

    Article  CAS  PubMed  Google Scholar 

  39. Munch C, Zhu BG, Leven A, Stamm S, Einkorn H, Schwalenstocker B et al. Differential regulation of 5′ splice variants of the glutamate transporter EAAT2 in an in vivo model of chemical hypoxia induced by 3-nitropropionic acid. J Neurosci Res 2003; 71: 819–825.

    Article  CAS  PubMed  Google Scholar 

  40. Lauriat TL, Schmeidler J, McInnes LA . Early rapid rise in EAAT2 expression follows the period of maximal seizure susceptibility in human brain. Neurosci Lett 2007; 412: 89–94.

    Article  CAS  PubMed  Google Scholar 

  41. Guo H, Lai L, Butchbach ME, Lin CL . Human glioma cells and undifferentiated primary astrocytes that express aberrant EAAT2 mRNA inhibit normal EAAT2 protein expression and prevent cell death. Mol Cell Neurosci 2002; 21: 546–560.

    Article  CAS  PubMed  Google Scholar 

  42. Lin CL, Bristol LA, Jin L, Dykes-Hoberg M, Crawford T, Clawson L et al. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998; 20: 589–602.

    Article  CAS  PubMed  Google Scholar 

  43. Kalandadze A, Wu Y, Fournier K, Robinson MB . Identification of motifs involved in endoplasmic reticulum retention-forward trafficking of the GLT-1 subtype of glutamate transporter. J Neurosci 2004; 24: 5183–5192.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Nagy E, Maquat LE . A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem Sci 1998; 23: 198–199.

    Article  CAS  PubMed  Google Scholar 

  45. Nagai M, Abe K, Okamoto K, Itoyama Y . Identification of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients. Neurosci Lett 1998; 244: 165–168.

    Article  CAS  PubMed  Google Scholar 

  46. Honig LS, Chambliss DD, Bigio EH, Carroll SL, Elliott JL . Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls. Neurology 2000; 55: 1082–1088.

    Article  CAS  PubMed  Google Scholar 

  47. Flowers JM, Powell JF, Leigh PN, Andersen P, Shaw CE . Intron 7 retention and exon 9 skipping EAAT2 mRNA variants are not associated with amyotrophic lateral sclerosis. Ann Neurol 2001; 49: 643–649.

    Article  CAS  PubMed  Google Scholar 

  48. Lehre KP, Levy LM, Ottersen OP, Storm-Mathisen J, Danbolt NC . Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J Neurosci 1995; 15: 1835–1853.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Chaudhry FA, Lehre KP, van Lookeren Campagne M, Ottersen OP, Danbolt NC, Storm-Mathisen J . Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 1995; 15: 711–720.

    Article  CAS  PubMed  Google Scholar 

  50. Pitt D, Nagelmeier IE, Wilson HC, Raine CS . Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis. Neurology 2003; 61: 1113–1120.

    Article  CAS  PubMed  Google Scholar 

  51. Domercq M, Etxebarria E, Perez-Samartin A, Matute C . Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition. Glia 2005; 52: 36–46.

    Article  PubMed  Google Scholar 

  52. Rauen T, Kanner BI . Localization of the glutamate transporter GLT-1 in rat and macaque monkey retinae. Neurosci Lett 1994; 169: 137–140.

    Article  CAS  PubMed  Google Scholar 

  53. Kugler P, Beyer A . Expression of glutamate transporters in human and rat retina and rat optic nerve. Histochem Cell Biol 2003; 120: 199–212.

    Article  CAS  PubMed  Google Scholar 

  54. Chen W, Mahadomrongkul V, Berger UV, Bassan M, DeSilva T, Tanaka K et al. The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons. J Neurosci 2004; 24: 1136–1148.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Berger UV, DeSilva TM, Chen W, Rosenberg PA . Cellular and subcellular mRNA localization of glutamate transporter isoforms GLT1a and GLT1b in rat brain by in situ hybridization. J Comp Neurol 2005; 492: 78–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Bassan M, Liu H, Chen W, Irwin N, Rosenberg PA . Functional interaction of glt1b, a variant form of the glutamate transporter glt1, with pick1. Soc Neurosci Abstract 2003 (program # 372.8).

  57. Marie H, Attwell D . C-terminal interactions modulate the affinity of GLAST glutamate transporters in salamander retinal glial cells. J Physiol 1999; 520: 393–397.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Schmitt A, Asan E, Puschel B, Jons T, Kugler P . Expression of the glutamate transporter GLT1 in neural cells of the rat central nervous system: non-radioactive in situ hybridization and comparative immunocytochemistry. Neuroscience 1996; 71: 989–1004.

    Article  CAS  PubMed  Google Scholar 

  59. Torp R, Hoover F, Danbolt NC, Storm-Mathisen J, Ottersen OP . Differential distribution of the glutamate transporters GLT1 and rEAAC1 in rat cerebral cortex and thalamus: an in situ hybridization analysis. Anat Embryol (Berl) 1997; 195: 317–326.

    Article  CAS  Google Scholar 

  60. Berger UV, Hediger MA . Comparative analysis of glutamate transporter expression in rat brain using differential double in situ hybridization. Anat Embryol (Berl) 1998; 198: 13–30.

    Article  CAS  Google Scholar 

  61. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE et al. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005; 433: 73–77.

    Article  CAS  PubMed  Google Scholar 

  62. Williams SM, Sullivan RK, Scott HL, Finkelstein DI, Colditz PB, Lingwood BE et al. Glial glutamate transporter expression patterns in brains from multiple mammalian species. Glia 2005; 49: 520–541.

    Article  PubMed  Google Scholar 

  63. Pow DV, Naidoo T, Lingwood BE, Healy GN, Williams SM, Sullivan RK et al. Loss of glial glutamate transporters and induction of neuronal expression of GLT-1B in the hypoxic neonatal pig brain. Brain Res Dev Brain Res 2004; 153: 1–11.

    Article  CAS  PubMed  Google Scholar 

  64. French PJ, Bliss TV, O’Connor V . Ntab, a novel non-coding RNA abundantly expressed in rat brain. Neuroscience 2001; 108: 207–215.

    Article  CAS  PubMed  Google Scholar 

  65. Katagiri H, Tanaka K, Manabe T . Requirement of appropriate glutamate concentrations in the synaptic cleft for hippocampal LTP induction. Eur J Neurosci 2001; 14: 547–553.

    Article  CAS  PubMed  Google Scholar 

  66. Bristol LA, Rothstein JD . Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann Neurol 1996; 39: 676–679.

    Article  CAS  PubMed  Google Scholar 

  67. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW . Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995; 38: 73–84.

    Article  CAS  PubMed  Google Scholar 

  68. Fray AE, Ince PG, Banner SJ, Milton ID, Usher PA, Cookson MR et al. The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: an immunohistochemical study. Eur J Neurosci 1998; 10: 2481–2489.

    Article  CAS  PubMed  Google Scholar 

  69. Maragakis NJ, Dykes-Hoberg M, Rothstein JD . Altered expression of the glutamate transporter EAAT2b in neurological disease. Ann Neurol 2004; 55: 469–477.

    Article  CAS  PubMed  Google Scholar 

  70. Wilson JM, Khabazian I, Pow DV, Craig UK, Shaw CA . Decrease in glial glutamate transporter variants and excitatory amino acid receptor down-regulation in a murine model of ALS-PDC. Neuromolecular Med 2003; 3: 105–118.

    Article  CAS  PubMed  Google Scholar 

  71. Guo H, Lai L, Butchbach ME, Stockinger MP, Shan X, Bishop GA et al. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. Hum Mol Genet 2003; 12: 2519–2532.

    Article  CAS  PubMed  Google Scholar 

  72. Pardo AC, Wong V, Benson LM, Dykes M, Tanaka K, Rothstein JD et al. Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1(G93A) mice. Exp Neurol 2006; 201: 120–130.

    Article  CAS  PubMed  Google Scholar 

  73. Smith RE, Haroutunian V, Davis KL, Meador-Woodruff JH . Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. Am J Psychiatry 2001; 158: 1393–1399.

    Article  CAS  PubMed  Google Scholar 

  74. Ohnuma T, Augood SJ, Arai H, McKenna PJ, Emson PC . Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia. Brain Res Mol Brain Res 1998; 56: 207–217.

    Article  CAS  PubMed  Google Scholar 

  75. Ohnuma T, Tessler S, Arai H, Faull RL, McKenna PJ, Emson PC . Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus. Brain Res Mol Brain Res 2000; 85: 24–31.

    Article  CAS  PubMed  Google Scholar 

  76. Ohnuma T, Suzuki T, Arai H . Hypothesis: minimal changes in neural transmission in schizophrenia: decreased glutamatergic and GABAergic functions in the prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 889–894.

    Article  CAS  PubMed  Google Scholar 

  77. Egan MF, Straub RE, Goldberg TE, Yakub I, Callicott JH, Hariri AR et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci USA 2004; 101: 12604–12609.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. McCullumsmith RE, Meador-Woodruff JH . Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology 2002; 26: 368–375.

    Article  CAS  PubMed  Google Scholar 

  79. Melone M, Vitellaro-Zuccarello L, Vallejo-Illarramendi A, Perez-Samartin A, Matute C, Cozzi A et al. The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine. Mol Psychiatry 2001; 6: 380–386.

    Article  CAS  PubMed  Google Scholar 

  80. Schmitt A, Zink M, Petroianu G, May B, Braus DF, Henn FA . Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brain. Neurosci Lett 2003; 347: 81–84.

    Article  CAS  PubMed  Google Scholar 

  81. Schneider JS, Wade T, Lidsky TI . Chronic neuroleptic treatment alters expression of glial glutamate transporter GLT-1 mRNA in the striatum. Neuroreport 1998; 9: 133–136.

    Article  CAS  PubMed  Google Scholar 

  82. Vallejo-Illarramendi A, Torres-Ramos M, Melone M, Conti F, Matute C . Clozapine reduces GLT-1 expression and glutamate uptake in astrocyte cultures. Glia 2005; 50: 276–279.

    Article  PubMed  Google Scholar 

  83. Reagan LP, Rosell DR, Wood GE, Spedding M, Munoz C, Rothstein J et al. Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine. Proc Natl Acad Sci USA 2004; 101: 2179–2184.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Zschocke J, Bayatti N, Clement AM, Witan H, Figiel M, Engele J et al. Differential promotion of glutamate transporter expression and function by glucocorticoids in astrocytes from various brain regions. J Biol Chem 2005; 280: 34924–34932.

    Article  CAS  PubMed  Google Scholar 

  85. Autry AE, Grillo CA, Piroli GG, Rothstein JD, McEwen BS, Reagan LP . Glucocorticoid Regulation of GLT-1 Glutamate Transporter Isoform Expression in the Rat Hippocampus. Neuroendocrinology 2006; 83: 371–379.

    Article  CAS  PubMed  Google Scholar 

  86. Wood GE, Young LT, Reagan LP, Chen B, McEwen BS . Stress-induced structural remodeling in hippocampus: prevention by lithium treatment. Proc Natl Acad Sci USA 2004; 101: 3973–3978.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Dixon JF, Hokin LE . Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. Proc Natl Acad Sci USA 1998; 95: 8363–8368.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Grunewald M, Kanner B . Conformational changes monitored on the glutamate transporter GLT-1 indicate the existence of two neurotransmitter-bound states. J Biol Chem 1995; 270: 17017–17024.

    Article  CAS  PubMed  Google Scholar 

  89. Zelenaia O, Schlag BD, Gochenauer GE, Ganel R, Song W, Beesley JS et al. Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-kappaB. Mol Pharmacol 2000; 57: 667–678.

    Article  CAS  PubMed  Google Scholar 

  90. Li LB, Toan SV, Zelenaia O, Watson DJ, Wolfe JH, Rothstein JD et al. Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT-1/EAAT2 subtype. J Neurochem 2006; 97: 759–771.

    Article  CAS  PubMed  Google Scholar 

  91. Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA 2005; 102: 15653–15658.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Hahn CG, Friedman E . Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder. Bipolar Disord 1999; 1: 81–86.

    Article  CAS  PubMed  Google Scholar 

  93. Kalandadze A, Wu Y, Robinson MB . Protein kinase C activation decreases cell surface expression of the GLT-1 subtype of glutamate transporter. Requirement of a carboxyl-terminal domain and partial dependence on serine 486. J Biol Chem 2002; 277: 45741–45750.

    Article  CAS  PubMed  Google Scholar 

  94. Gonzalez MI, Susarla BT, Robinson MB . Evidence that protein kinase Calpha interacts with and regulates the glial glutamate transporter GLT-1. J Neurochem 2005; 94: 1180–1188.

    Article  CAS  PubMed  Google Scholar 

  95. Rodriguez-Kern A, Gegelashvili M, Schousboe A, Zhang J, Sung L, Gegelashvili G . Beta-amyloid and brain-derived neurotrophic factor, BDNF, up-regulate the expression of glutamate transporter GLT-1/EAAT2 via different signaling pathways utilizing transcription factor NF-kappaB. Neurochem Int 2003; 43: 363–370.

    Article  CAS  PubMed  Google Scholar 

  96. Thal DR . Excitatory amino acid transporter EAAT-2 in tangle-bearing neurons in Alzheimer's disease. Brain Pathol 2002; 12: 405–411.

    Article  CAS  Google Scholar 

  97. Li S, Mallory M, Alford M, Tanaka S, Masliah E . Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol 1997; 56: 901–911.

    Article  CAS  PubMed  Google Scholar 

  98. Masliah E, Alford M, Mallory M, Rockenstein E, Moechars D, Van Leuven F . Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice. Exp Neurol 2000; 163: 381–387.

    Article  CAS  PubMed  Google Scholar 

  99. Proper EA, Hoogland G, Kappen SM, Jansen GH, Rensen MG, Schrama LH et al. Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 2002; 125: 32–43.

    Article  CAS  PubMed  Google Scholar 

  100. Hoogland G, Van Oort RJ, Proper EA, Jansen GH, Van Rijen PC, Van Veelen CW et al. Alternative splicing of glutamate transporter EAAT2 RNA in neocortex and hippocampus of temporal lobe epilepsy patients. Epilepsy Res 2004; 59: 75–82.

    Article  CAS  PubMed  Google Scholar 

  101. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997; 276: 1699–1702.

    Article  CAS  PubMed  Google Scholar 

  102. Wong M, Ess KC, Uhlmann EJ, Jansen LA, Li W, Crino PB et al. Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model. Ann Neurol 2003; 54: 251–256.

    Article  CAS  PubMed  Google Scholar 

  103. Ingram EM, Wiseman JW, Tessler S, Emson PC . Reduction of glial glutamate transporters in the parietal cortex and hippocampus of the EL mouse. J Neurochem 2001; 79: 564–575.

    Article  CAS  PubMed  Google Scholar 

  104. Akbar MT, Rattray M, Williams RJ, Chong NW, Meldrum BS . Reduction of GABA and glutamate transporter messenger RNAs in the severe-seizure genetically epilepsy-prone rat. Neuroscience 1998; 85: 1235–1251.

    Article  CAS  PubMed  Google Scholar 

  105. Friedman MJ, Sharieff GQ . Seizures in children. Pediatr Clin North Am 2006; 53: 257–277.

    Article  PubMed  Google Scholar 

  106. Rossi DJ, Oshima T, Attwell D . Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 2000; 403: 316–321.

    Article  CAS  PubMed  Google Scholar 

  107. Mitani A, Tanaka K . Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J Neurosci 2003; 23: 7176–7182.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Rao VL, Bowen KK, Dempsey RJ . Transient focal cerebral ischemia down-regulates glutamate transporters GLT-1 and EAAC1 expression in rat brain. Neurochem Res 2001; 26: 497–502.

    Article  CAS  PubMed  Google Scholar 

  109. Rao VL, Dogan A, Bowen KK, Todd KG, Dempsey RJ . Antisense knockdown of the glial glutamate transporter GLT-1 exacerbates hippocampal neuronal damage following traumatic injury to rat brain. Eur J Neurosci 2001; 13: 119–128.

    CAS  PubMed  Google Scholar 

  110. Cimarosti H, Jones NM, O’Shea RD, Pow DV, Salbego C, Beart PM . Hypoxic preconditioning in neonatal rat brain involves regulation of excitatory amino acid transporter 2 and estrogen receptor alpha. Neurosci Lett 2005; 385: 52–57.

    Article  CAS  PubMed  Google Scholar 

  111. Martin LJ, Brambrink AM, Lehmann C, Portera-Cailliau C, Koehler R, Rothstein J et al. Hypoxia-ischemia causes abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum. Ann Neurol 1997; 42: 335–348.

    Article  CAS  PubMed  Google Scholar 

  112. Arzberger T, Krampfl K, Leimgruber S, Weindl A . Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease--an in situ hybridization study. J Neuropathol Exp Neurol 1997; 56: 440–454.

    Article  CAS  PubMed  Google Scholar 

  113. Behrens PF, Franz P, Woodman B, Lindenberg KS, Landwehrmeyer GB . Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain 2002; 125: 1908–1922.

    Article  CAS  PubMed  Google Scholar 

  114. Lievens JC, Woodman B, Mahal A, Spasic-Boscovic O, Samuel D, Kerkerian-Le Goff L et al. Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol Dis 2001; 8: 807–821.

    Article  CAS  PubMed  Google Scholar 

  115. Yi JH, Pow DV, Hazell AS . Early loss of the glutamate transporter splice-variant GLT-1v in rat cerebral cortex following lateral fluid-percussion injury. Glia 2005; 49: 121–133.

    Article  PubMed  Google Scholar 

  116. Rao VL, Baskaya MK, Dogan A, Rothstein JD, Dempsey RJ . Traumatic brain injury down-regulates glial glutamate transporter (GLT-1 and GLAST) proteins in rat brain. J Neurochem 1998; 70: 2020–2027.

    CAS  PubMed  Google Scholar 

  117. van Landeghem FK, Stover JF, Bechmann I, Bruck W, Unterberg A, Buhrer C et al. Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat. Glia 2001; 35: 167–179.

    Article  CAS  PubMed  Google Scholar 

  118. Ikematsu K, Tsuda R, Kondo T, Nakasono I . The expression of excitatory amino acid transporter 2 in traumatic brain injury. Forensic Sci Int 2002; 130: 83–89.

    Article  CAS  PubMed  Google Scholar 

  119. Figiel M, Maucher T, Rozyczka J, Bayatti N, Engele J . Regulation of glial glutamate transporter expression by growth factors. Exp Neurol 2003; 183: 124–135.

    Article  CAS  PubMed  Google Scholar 

  120. Rozyczka J, Figiel M, Engele J . Endothelins negatively regulate glial glutamate transporter expression. Brain Pathol 2004; 14: 406–414.

    Article  CAS  PubMed  Google Scholar 

  121. Sullivan RK, Woldemussie E, Macnab L, Ruiz G, Pow DV . Evoked Expression of the Glutamate Transporter GLT-1c in Retinal Ganglion Cells in Human Glaucoma and in a Rat Model. Invest Ophthalmol Vis Sci 2006; 47: 3853–3859.

    Article  PubMed  Google Scholar 

  122. Wang Z, Pekarskaya O, Bencheikh M, Chao W, Gelbard HA, Ghorpade A et al. Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology 2003; 312: 60–73.

    Article  CAS  PubMed  Google Scholar 

  123. Porcheray F, Leone C, Samah B, Rimaniol AC, Dereuddre-Bosquet N, Gras G . Glutamate metabolism in HIV-infected macrophages: implications for the CNS. Am J Physiol Cell Physiol 2006; 291: C618–C626.

    Article  CAS  PubMed  Google Scholar 

  124. Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky DJ, Fisher PB . Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 2005; 353: 8–15.

    Article  CAS  PubMed  Google Scholar 

  125. Nakagawa T, Satoh M . Involvement of glial glutamate transporters in morphine dependence. Ann NY Acad Sci 2004; 1025: 383–388.

    Article  CAS  PubMed  Google Scholar 

  126. Xu NJ, Bao L, Fan HP, Bao GB, Pu L, Lu YJ et al. Morphine withdrawal increases glutamate uptake and surface expression of glutamate transporter GLT1 at hippocampal synapses. J Neurosci 2003; 23: 4775–4784.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  127. Ozawa T, Nakagawa T, Shige K, Minami M, Satoh M . Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal. Brain Res 2001; 905: 254–258.

    Article  CAS  PubMed  Google Scholar 

  128. Fujio M, Nakagawa T, Sekiya Y, Ozawa T, Suzuki Y, Minami M et al. Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine- and morphine-induced conditioned place preference in rats. Eur J Neurosci 2005; 22: 2744–2754.

    Article  PubMed  Google Scholar 

  129. Ozawa T, Nakagawa T, Sekiya Y, Minami M, Satoh M . Effect of gene transfer of GLT-1, a glutamate transporter, into the locus coeruleus by recombinant adenoviruses on morphine physical dependence in rats. Eur J Neurosci 2004; 19: 221–226.

    Article  PubMed  Google Scholar 

  130. Shimada F, Shiga Y, Morikawa M, Kawazura H, Morikawa O, Matsuoka T et al. The neuroprotective agent MS-153 stimulates glutamate uptake. Eur J Pharmacol 1999; 386: 263–270.

    Article  CAS  PubMed  Google Scholar 

  131. Nakagawa T, Ozawa T, Shige K, Yamamoto R, Minami M, Satoh M . Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator. Eur J Pharmacol 2001; 419: 39–45.

    Article  CAS  PubMed  Google Scholar 

  132. Nakagawa T, Fujio M, Ozawa T, Minami M, Satoh M . Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice. Behav Brain Res 2005; 156: 233–239.

    Article  CAS  PubMed  Google Scholar 

  133. Tzschentke TM, Schmidt WJ . Blockade of morphine- and amphetamine-induced conditioned place preference in the rat by riluzole. Neurosci Lett 1998; 242: 114–116.

    Article  CAS  PubMed  Google Scholar 

  134. The Autism Genome Project Consortium Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007; 39: 319–328.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA

    T L Lauriat & L A McInnes

  2. Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY, USA

    L A McInnes

Authors
  1. T L Lauriat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L A McInnes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L A McInnes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lauriat, T., McInnes, L. EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders. Mol Psychiatry 12, 1065–1078 (2007). https://doi.org/10.1038/sj.mp.4002065

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4002065

Keywords

This article is cited by

Search

Advanced search

Quick links